HSTOHistogen Inc. Common Stock US Stock
Open: $2.44 High: $2.52 Low: $2.36 Close: $2.46
Range: 2022-08-08 - 2022-08-09Volume:144,676
Powered by Finage Stock APIDelayed data
Histogen Inc. Common Stock 10655 SORRENTO VALLEY ROAD https://www.histogen.comHistogen Inc is a clinical-stage therapeutics company focused on developing proprietary hypoxia-generated growth factor technology platform and stem cell-free biologic products as potential first-in-class restorative therapeutics that ignite the body's natural process to repair and maintain healthy biological function. Under its biologics technology platform, the product candidates in development are HST-003, a treatment for joint cartilage repair, and HST-004, a treatment for spinal disc repair. It also has a pipeline of clinical and preclinical small molecule pan-caspase and caspase selective inhibitors focused on treatments for infectious and inflammatory diseases that the company intends to develop.
- Employees: 22